Zenara Pharma launches Paxzen tablet against mild to moderate COVID

Sep 09, 2022

Hyderabad (Telangana) [India], September 9 : Hyderabad-based Zenara Pharma, has announced that it has launched Nirmatrelvir and Ritonavir tablets in a combi pack as...

UK's RECOVERY trial found anti-viral HIV drug "ineffective"on COVID-19 patients, opine for revision in the treatment guidelines

Jun 30, 2020

New Delhi [India], June 30 : Researchers from UK's RECOVERY trial (Randomised Evaluation of COVID-19 Therapy) have claimed to have found no benefit from...

WHO halts hydroxychloroquine and combination of HIV drug trials among hospitalised COVID-19 patients

Jul 05, 2020

Geneva [Switzerland], July 5 The World Health Organisation on Saturday has halted its trials of the malaria drug hydroxychloroquine and combination of HIV...

Four drugs for COVID-19 appear to have little or no effect on reducing mortality: Solidarity trial results

Oct 17, 2020

New Delhi [India], October 17 : The interim analysis of WHO's Solidarity Trial has revealed that 4 repurposed drugs for COVID-19--remdesivir, hydroxychloroquine, lopinavir/ritonavir and...

Four repurposed drugs have no effect on reducing mortality in COVID-19 cases: WHO

Oct 16, 2020

New Delhi [India], October 16 : The interim analysis of World Health Organisation (WHO)'s Solidarity Trial has revealed that four repurposed drugs for COVID-19--remdesivir,...

Hetero's 'Nirmacom' is world's first generic version of COVID-19 oral drug 'PAXLOVID' to receive WHO Prequalification

Dec 27, 2022

Hyderabad (Telangana) [India], December 27 (ANI/PRNewswire): Hetero, India's leading pharmaceutical company with the widest global reach, today announced the receipt of World Health Organization...